Stability Analysis of a Ratio-Dependent Predator-Prey Model Incorporating a Prey Refuge

A ratio-dependent predator-prey model incorporating a prey refuge with disease in the prey population is formulated and analyzed. The effects of time delay due to the gestation of the predator and stage structure for the predator on the dynamics of the system are concerned. By analyzing the corresponding characteristic equations, the local stability of a predator-extinction equilibrium and a coexistence equilibrium of the system is discussed, respectively. Further, it is proved that the system undergoes a Hopf bifurcation at the coexistence equilibrium, when τ=τ0. By comparison arguments, sufficient conditions are obtained for the global stability of the predator-extinction equilibrium. By using an iteration technique, sufficient conditions are derived for the global attractivity of the coexistence equilibrium of the proposed system

Stability and Bifurcation Analysis on an Ecoepidemiological Model with Stage Structure and Time Delay

An ecoepidemiological predator-prey model with stage structure for the predator and time delay due to the gestation of the predator is investigated. The effects of a prey refuge with disease in the prey population are concerned. By analyzing the corresponding characteristic equations, the local stability of each of the feasible equilibria of the model is discussed. Further, it is proved that the model undergoes a Hopf bifurcation at the positive equilibrium. By means of appropriate Lyapunov functions and LaSalle’s invariance principle, sufficient conditions are obtained for the global stability of the semitrivial boundary equilibria. By using an iteration technique, sufficient conditions are derived for the global attractiveness of the positive equilibrium

Optimized speed control for electric vehicles on dynamic wireless charging lanes: An eco-driving approach

As the adoption of Electric Vehicles (EVs) intensifies, two primary challenges emerge: limited range due to battery constraints and extended charging times. The traditional charging stations, particularly those near highways, exacerbate these issues with necessary detours, inconsistent service levels, and unpredictable waiting durations. The emerging technology of dynamic wireless charging lanes (DWCLs) may alleviate range anxiety and eliminate long charging stops; however, the driving speed on DWCL significantly affects charging efficiency and effective charging time. Meanwhile, the existing research has addressed load balancing optimization on Dynamic Wireless Charging (DWC) systems to a limited extent. To address this critical issue, this study introduces an innovative eco-driving speed control strategy, providing a novel solution to the multi-objective optimization problem of speed control on DWCL. We utilize mathematical programming methods and incorporate the longitudinal dynamics of vehicles to provide an accurate physical model of EVs. Three objective functions are formulated to tackle the challenges at hand: reducing travel time, increasing charging efficiency, and achieving load balancing on DWCL, which corresponds to four control strategies. The results of numerical tests indicate that a comprehensive control strategy, which considers all objectives, achieves a minor sacrifice in travel time reduction while significantly improving energy efficiency and load balancing. Furthermore, by defining the energy demand and speed range through an upper operation limit, a relatively superior speed control strategy can be selected. This work contributes to the discourse on DWCL integration into modern transportation systems, enhancing the EV driving experience on major roads

Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses

Sequence signatures of multidonor broadly neutralizing influenza antibodies can be used to quantify the prevalence of B cells with virus-neutralizing potential to accelerate development of broadly protective vaccine strategies. Antibodies of the same class share similar recognition modes and developmental pathways, and several antibody classes have been identified that neutralize diverse group 1- and group 2-influenza A viruses and have been observed in multiple human donors. One such multidonor antibody class, the HV6-1-derived class, targets the stem region of hemagglutinin with extraordinary neutralization breadth. Here, we use an iterative process to combine informatics, biochemical, and structural analyses to delineate an improved sequence signature for HV6-1-class antibodies. Based on sequence and structure analyses of known HV6-1 class antibodies, we derived a more inclusive signature (version 1), which we used to search for matching B-cell transcripts from published next-generation sequencing datasets of influenza vaccination studies. We expressed selected antibodies, evaluated their function, and identified amino acid-level requirements from which to refine the sequence signature (version 2). The cryo-electron microscopy structure for one of the signature-identified antibodies in complex with hemagglutinin confirmed motif recognition to be similar to known HV6-1-class members, MEDI8852 and 56.a.09, despite differences in recognition-loop length. Threading indicated the refined signature to have increased accuracy, and signature-identified heavy chains, when paired with the light chain of MEDI8852, showed neutralization comparable to the most potent members of the class. Incorporating sequences of additional class members thus enables an improved sequence signature for HV6-1-class antibodies, which can identify class members with increased accuracy

Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling

Recombinant adenoviral vectors (rAds) are lead vaccine candidates for protection against a variety of pathogens, including Ebola, HIV, tuberculosis, and malaria, due to their ability to potently induce T cell immunity in humans. However, the ability to induce protective cellular immunity varies among rAds. Here, we assessed the mechanisms that control the potency of CD8 T cell responses in murine models following vaccination with human-, chimpanzee-, and simian-derived rAds encoding SIV-Gag antigen (Ag). After rAd vaccination, we quantified Ag expression and performed expression profiling of innate immune response genes in the draining lymph node. Human-derived rAd5 and chimpanzee-derived chAd3 were the most potent rAds and induced high and persistent Ag expression with low innate gene activation, while less potent rAds induced less Ag expression and robustly induced innate immunity genes that were primarily associated with IFN signaling. Abrogation of type I IFN or stimulator of IFN genes (STING) signaling increased Ag expression and accelerated CD8 T cell response kinetics but did not alter memory responses or protection. These findings reveal that the magnitude of rAd-induced memory CD8 T cell immune responses correlates with Ag expression but is independent of IFN and STING and provide criteria for optimizing protective CD8 T cell immunity with rAd vaccines

Functional Profiling of Antibody Immune Repertoires in Convalescent Zika Virus Disease Patients

The re-emergence of Zika virus (ZIKV) caused widespread infections that were linked to Guillain-Barré syndrome in adults and congenital malformation in fetuses, and epidemiological data suggest that ZIKV infection can induce protective antibody responses. A more detailed understanding of anti-ZIKV antibody responses may lead to enhanced antibody discovery and improved vaccine designs against ZIKV and related flaviviruses. Here, we applied recently-invented library-scale antibody screening technologies to determine comprehensive functional molecular and genetic profiles of naturally elicited human anti-ZIKV antibodies in three convalescent individuals. We leveraged natively paired antibody yeast display and NGS to predict antibody cross-reactivities and coarse-grain antibody affinities, to perform in-depth immune profiling of IgM, IgG, and IgA antibody repertoires in peripheral blood, and to reveal virus maturation state-dependent antibody interactions. Repertoire-scale comparison of ZIKV VLP-specific and non-specific antibodies in the same individuals also showed that mean antibody somatic hypermutation levels were substantially influenced by donor-intrinsic characteristics. These data provide insights into antiviral antibody responses to ZIKV disease and outline systems-level strategies to track human antibody immune responses to emergent viral infections

Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination

<div><h3>Background</h3><p>The Step trial raised the possibility that uncircumcised men with pre-existing Ad5 neutralizing antibodies carried an increased risk of HIV infection after vaccination. Thus, understanding Ad seropositivity in humans is important to the development of an AIDS vaccine. Here, we analyze the impact of different Ad5-specific neutralizing antibodies on immune function and clinical outcome.</p> <h3>Methods and Findings</h3><p>Ad seropositivity in the Step trial volunteers was analyzed using chimeric rAd5/35 vectors to characterize their specificity for Ad5 fiber and non-fiber external (capsid) proteins. Immune responses and HIV seropositivity were correlated with the specificity of Ad5-neutralizing antibodies. Neutralizing antibodies induced by the vaccine in Ad5 seronegative subjects were directed preferentially to Ad5 capsid proteins, although some fiber-neutralizing antibodies could be detected. Pre-vaccination Ad5 serostatus did not affect the capsid-directed response after three vaccinations. In contrast, anti-fiber antibody titers were significantly higher in volunteers who were Ad5 seropositive prior to vaccination. Those Ad5 seropositive subjects who generated anti-capsid responses showed a marked reduction in vaccine-induced CD8 responses. Unexpectedly, anti-vector immunity differed qualitatively in Ad5 seropositive participants who became HIV-1 infected compared to uninfected case controls; Ad5 seropositive participants who later acquired HIV had lower neutralizing antibodies to capsid. Moreover, Ad35 seropositivity was decreased in HIV-infected subjects compared with uninfected case controls, while seroprevalence for other serotypes including Ad14, Ad28 and Ad41 was similar in both groups.</p> <h3>Conclusions</h3><p>Together, these findings suggest that the case subjects were less immunologically responsive prior to infection. Subjects infected during the Step trial had qualitative differences in immunity that increased their risk of HIV-1 infection independent of vaccination.</p> </div